Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.3764
-0.0126 (-3.24%)
Apr 25, 2025, 12:00 PM EDT - Market open
Bolt Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 7.21 | 10.81 | 9.24 | 27.38 | 5.54 | Upgrade
|
| Short-Term Investments | 40.12 | 91.38 | 159.64 | 158.84 | 17.3 | Upgrade
|
| Cash & Short-Term Investments | 47.32 | 102.19 | 168.89 | 186.22 | 22.84 | Upgrade
|
| Cash Growth | -53.69% | -39.49% | -9.31% | 715.39% | -34.42% | Upgrade
|
| Other Receivables | 0.81 | 0.6 | - | - | - | Upgrade
|
| Receivables | 0.81 | 0.6 | - | - | - | Upgrade
|
| Prepaid Expenses | 1.84 | 2.74 | 3.86 | 2.94 | 2.52 | Upgrade
|
| Restricted Cash | 0.78 | - | - | - | - | Upgrade
|
| Other Current Assets | 0.06 | 0.18 | - | - | - | Upgrade
|
| Total Current Assets | 50.81 | 105.71 | 172.75 | 189.16 | 25.36 | Upgrade
|
| Property, Plant & Equipment | 24.9 | 24.08 | 28.53 | 30.6 | 16.35 | Upgrade
|
| Long-Term Investments | 22.88 | 26.41 | 23.94 | 85.35 | - | Upgrade
|
| Long-Term Deferred Charges | 0.05 | 0.37 | - | - | 2.36 | Upgrade
|
| Other Long-Term Assets | 0.99 | 3.22 | 2.59 | 2.61 | 2.47 | Upgrade
|
| Total Assets | 99.63 | 159.78 | 227.81 | 307.72 | 46.54 | Upgrade
|
| Accounts Payable | 1.51 | 2.99 | 3.59 | 3.57 | 1.6 | Upgrade
|
| Accrued Expenses | 8.34 | 12.49 | 15.14 | 12.38 | 6.66 | Upgrade
|
| Current Portion of Leases | 2.25 | 2.78 | 2.39 | 2.5 | 1.5 | Upgrade
|
| Current Unearned Revenue | 3.02 | 2.2 | 1.99 | 2.87 | 1.5 | Upgrade
|
| Other Current Liabilities | 0.74 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 15.86 | 20.46 | 23.12 | 21.33 | 11.26 | Upgrade
|
| Long-Term Leases | 22.96 | 17.44 | 20.22 | 21.85 | 9.38 | Upgrade
|
| Long-Term Unearned Revenue | 3.62 | 9.11 | 12.92 | 14.21 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.04 | 0.04 | 0.21 | 0.33 | Upgrade
|
| Total Liabilities | 42.43 | 47.04 | 56.3 | 57.6 | 20.97 | Upgrade
|
| Additional Paid-In Capital | 484.5 | 476.99 | 467.51 | 457.43 | 3.45 | Upgrade
|
| Retained Earnings | -427.4 | -364.29 | -295.09 | -206.99 | -108.4 | Upgrade
|
| Comprehensive Income & Other | 0.1 | 0.04 | -0.92 | -0.32 | - | Upgrade
|
| Total Common Equity | 57.2 | 112.74 | 171.51 | 250.12 | -104.95 | Upgrade
|
| Shareholders' Equity | 57.2 | 112.74 | 171.51 | 250.12 | 25.57 | Upgrade
|
| Total Liabilities & Equity | 99.63 | 159.78 | 227.81 | 307.72 | 46.54 | Upgrade
|
| Total Debt | 25.21 | 20.22 | 22.61 | 24.36 | 10.88 | Upgrade
|
| Net Cash (Debt) | 22.11 | 81.97 | 146.28 | 161.86 | 11.96 | Upgrade
|
| Net Cash Growth | -73.02% | -43.96% | -9.63% | 1253.27% | -51.46% | Upgrade
|
| Net Cash Per Share | 0.58 | 2.17 | 3.92 | 4.88 | 5.69 | Upgrade
|
| Filing Date Shares Outstanding | 38.34 | 38.13 | 37.81 | 37.47 | 36.33 | Upgrade
|
| Total Common Shares Outstanding | 38.34 | 38.11 | 37.8 | 37.4 | 2.13 | Upgrade
|
| Working Capital | 34.96 | 85.25 | 149.63 | 167.83 | 14.1 | Upgrade
|
| Book Value Per Share | 1.49 | 2.96 | 4.54 | 6.69 | -49.27 | Upgrade
|
| Tangible Book Value | 57.2 | 112.74 | 171.51 | 250.12 | -104.95 | Upgrade
|
| Tangible Book Value Per Share | 1.49 | 2.96 | 4.54 | 6.69 | -49.27 | Upgrade
|
| Machinery | 10.13 | 10.42 | 10.1 | 8.26 | 5.32 | Upgrade
|
| Leasehold Improvements | 0.29 | 0.29 | 0.27 | 0.15 | - | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.